Literature DB >> 7826823

The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid.

P Seideman1, F Lohrer, G G Graham, M W Duncan, K M Williams, R O Day.   

Abstract

1. A sensitive, stereospecific assay using gas chromatography-mass spectrometry (GC/MS) was established to measure the concentrations of the enantiomers of ibuprofen in small volumes (50 microliters) of blister fluid. 2. The concentrations of the enantiomers in blister fluid, assessed in eight patients, were similar to those in synovial fluid, both fluids behaving as peripheral compartments with respect to plasma. 3. The mean rate constants of transfer of R-ibuprofen into (0.14 +/- 0.06 h-1) and out of (0.20 +/- 0.04 h-1) blister fluid were not significantly different from those for synovial fluid (0.19 +/- 0.12 h-1, 0.34 +/- 0.11 h-1, respectively). Similarly, the mean rate constants of transfer of S-ibuprofen into (0.22 +/- 0.07 h-1) and out of (0.27 +/- 0.08 h-1) blister fluid were not significantly different from those for synovial fluid (0.29 +/- 0.10, 0.36 +/- 0.11 h-1). However, the correlations were poor between the transfer constants for each of the enantiomers between plasma, and both blister and synovial fluid (P > 0.2). 4. The complex rate constant of transfer of S-ibuprofen into blister fluid (0.22 +/- 0.07 h-1) was greater than that of R-ibuprofen (0.14 +/- 0.07 h-1), which may be explained by the lesser protein binding of the S-enantiomer.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826823      PMCID: PMC1364793          DOI: 10.1111/j.1365-2125.1994.tb04345.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  Isomeric inversion of ibuprofen (R)-enantiomer in humans.

Authors:  D G Kaiser; G J Vangiessen; R J Reischer; W J Wechter
Journal:  J Pharm Sci       Date:  1976-02       Impact factor: 3.534

2.  Stereoselective plasma protein binding of ibuprofen enantiomers.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Suction blister device for separation of viable epidermis from dermis.

Authors:  U Kiistala
Journal:  J Invest Dermatol       Date:  1968-02       Impact factor: 8.551

4.  Dermo-epidermal separation with suction. Electron microscopic and histochemical study of initial events of blistering on human skin.

Authors:  U Kiistala; K K Mustakallio
Journal:  J Invest Dermatol       Date:  1967-05       Impact factor: 8.551

5.  Correlation of serum concentrations of ibuprofen stereoisomers with clinical response in the treatment of hip and knee osteoarthritis.

Authors:  J D Bradley; A C Rudy; B P Katz; S I Ryan; L A Kalasinski; D C Brater; S D Hall; K D Brandt
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

6.  Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.

Authors:  J W Mouton; A M Horrevorts; P G Mulder; E P Prens; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

7.  S-ibuprofen versus ibuprofen-racemate. A randomized double-blind study in patients with rheumatoid arthritis.

Authors:  K P Stock; G Geisslinger; D Loew; W S Beck; G L Bach; K Brune
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

8.  Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans.

Authors:  T A Baillie; W J Adams; D G Kaiser; L S Olanoff; G W Halstead; H Harpootlian; G J Van Giessen
Journal:  J Pharmacol Exp Ther       Date:  1989-05       Impact factor: 4.030

9.  Pharmacokinetics of tiaprofenic acid in normal rabbits and rabbits subjected to joint immobilisation.

Authors:  I Meyer-Carrive; G G Graham; P Ghosh
Journal:  Agents Actions       Date:  1993-05

10.  In the search for new anticancer drugs. XXIV: Synthesis and anticancer activity of amino acids and dipeptides containing the 2-chloroethyl- and [N'-(2-chloroethyl)-N'-nitroso]-aminocarbonyl groups.

Authors:  G Sosnovsky; I Prakash; N U Rao
Journal:  J Pharm Sci       Date:  1993-01       Impact factor: 3.534

View more
  5 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 3.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

4.  Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis.

Authors:  L Gallelli; O Galasso; A Urzino; S Saccà; D Falcone; C Palleria; P Longo; A Corigliano; R Terracciano; R Savino; G Gasparini; G De Sarro; S R Southworth
Journal:  Clin Drug Investig       Date:  2012-12       Impact factor: 2.859

Review 5.  Topical Administration of Ibuprofen for Injured Athletes: Considerations, Formulations, and Comparison to Oral Delivery.

Authors:  Martin Anthony Christopher Manoukian; Christopher William Migdal; Amode Ravindra Tembhekar; Jerad Alexander Harris; Charles DeMesa
Journal:  Sports Med Open       Date:  2017-10-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.